✦ LIBER ✦

RADIATION IN HIGH-RISK PROSTATE CANCER: HOW MUCH IS ENOUGH?

✍ Scribed by Heather Payne

Book ID: 109054074
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 93 KB
Volume: 102
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2008.07701.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Maintenance bacillus Calmette-Guérin in

Maintenance bacillus Calmette-Guérin in high-risk nonmuscle-invasive bladder cancer : How much is enough?

✍ Marc Decobert; Hélène LaRue; François Harel; François Meyer; Yves Fradet; Louis 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Ten Years Results with High-dose Radioth

Ten Years Results with High-dose Radiotherapy and Risk-adapted Androgen Deprivation in Prostate Cancer: How Curable is T3 Disease?

✍ A. Zapatero; F. Garcia-Vicente; C. Martin de Vidales; I. Fernandez; A. Cruz Cond 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Maximum tumor diameter is not an indepen

Maximum tumor diameter is not an independent prognostic factor in high-risk localized prostate cancer

✍ I. M. van Oort; J. A. Witjes; D. E. G. Kok; L. A. L. M. Kiemeney; C. A. Hulsberg 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 252 KB

Cancer-specific mortality after radiatio

Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer

✍ Henry K. Tsai; Ming-Hui Chen; David G. McLeod; Peter R. Carroll; Jerome P. Richi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 2 views

## Abstract ## BACKGROUND. The presence of multiple determinants of aggressive cancer biology may impact prostate cancer‐specific mortality (PCSM) rates compared with fewer factors. The authors estimated PCSM after radiation therapy with short‐course androgen suppression therapy (RT+AST) or radica

Urethral toxicity vs. cancer control—Les

Urethral toxicity vs. cancer control—Lessons to be learned from high–dose rate brachytherapy combined with intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer

✍ Pirus Ghadjar; Cyrill A. Rentsch; Bernhard Isaak; Frank Behrensmeier; George N. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 360 KB 👁 1 views

Prostate cancer-specific mortality after

Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors

✍ Anthony V. D'Amico; Ming-Hui Chen; William J. Catalona; Leon Sun; Kimberly A. Ro 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 292 KB

## Abstract ## BACKGROUND. Estimates of prostate cancer‐specific mortality (PCSM) were determined after radical prostatectomy (RP) or radiation therapy (RT) in men with ≥1 high‐risk factors. ## METHODS. The study cohort comprised 948 men who underwent RP (N = 660) or RT (N = 288) for localized p